enGene Holdings Inc.
ENGN · NASDAQ
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Market Cap | $369 | $395 | $471 | $316 |
| - Cash | $50 | $173 | $82 | $0 |
| + Debt | $32 | $25 | $10 | $0 |
| Enterprise Value | $350 | $247 | $399 | $316 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$114 | -$52 | -$95 | $0 |
| % Margin | – | – | – | – |
| Net Income | $117 | -$55 | -$100 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.29 | -1.46 | -4.24 | 0.002 |
| % Growth | -56.8% | 65.6% | -223,257.9% | – |
| Operating Cash Flow | -$99 | -$48 | -$25 | -$18 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$101 | -$49 | -$25 | -$18 |